Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma ...

Under the agreement, Rhythm has agreed to repay $6.3 million in cash to RareStone. Rhythm also agreed to return all shares of RareStone that were acquired under the original agreement for no ...

Kennedy Jr., met with executives at major companies across the food and beverage industry, including PepsiCo, General Mills, and others. He informed industry leaders that eliminating artificial dyes ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...

Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...